QUOTE AND NEWS
Bloomberg  Nov 17  Comment 
(Update1) Levels of “bad” cholesterol in the U.S. fell by one-third from 1999 to 2006 as more people took cholesterol-lowering drugs, U.S. researchers reported.
FierceBiotech  Nov 17  Comment 
Isis Pharmaceuticals (ISIS) says that its experimental cholesterol drug mipomersen hit its primary endpoint in a late-stage trial, cutting levels of LDL by an average of 25 percent among patients genetically inclined to develop high cholesterol....
StreetInsider.com  Nov 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Lydall%2C+Inc.+%28LDL%29+Appoints+Erika+K.+Turner+as+CFO/5066055.html for the full story.
StreetInsider.com  Oct 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Igoe+Appointed+Associated+General+Counsel+and+Assistant+Corporate+Secretary+at+Lydall+%28LDL%29/5017734.html for the full story.
MedPage Today  Aug 7  Comment 
Patients with coronary artery disease maintained target LDL cholesterol levels for two years after discharge from a disease-management program when they received periodic reminders to schedule lipid assessments.
StreetInsider.com  Aug 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Lydall+%28LDL%29+Swings+to+Q2+Loss+of+%240.24/4837295.html for the full story.
Bloomberg  Jun 22  Comment 
The proportion of Americans who lowered their so-called “bad” cholesterol through drugs and other treatments more than doubled in the last decade, a company-funded study shows.
New York Times  Jun 9  Comment 
Overweight adults who ate a low-carbohydrate vegan diet lost weight and showed large drops in “bad” cholesterol.
Marketwire  Apr 30  Comment 
MANCHESTER, CT -- (Marketwire) -- 04/30/09 -- LYDALL, INC. (NYSE: LDL) today announced financial results for the first quarter ended March 31, 2009. Net sales for the quarter ended March 31, 2009 were $54.3 million compared with $89.9 million for the
Marketwire  Apr 21  Comment 
MANCHESTER, CT -- (Marketwire) -- 04/21/09 -- Lydall, Inc. (NYSE: LDL) announced today that it will release its financial results for the first quarter ended March 31, 2009 on Thursday, April 30, 2009 before the market opens. A conference call,
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
LDL AT A GLANCE
P/E -3.76 
EV/EBITDA -4.24 
ROA -9.8%VERY LOW
ROE -14.1%AVG
Debt to Equity 0.427LOW
Current Ratio 2.50AVG
Interest Coverage Ratio -53.5VERY LOW
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki